MS.US Weekly Report · 2026-W37
Morgan Stanley’s stock declined 0.86% this week with a 3% intra-week range. Despite institutional ratings remaining constructive with 84% buy and hold recommendations, capital flows show a net outflow as institutional investors reduce positions while retail capital flows in. Earnings remain robust with latest quarter EPS growing 62% year-over-year, while current valuation sits in the lower-middle range of the past 5 years, highlighting a divergence between valuation and fundamentals worth monitoring.
Price Action
MS.US closed at 214.380 USD this week, down 0.86% from the week’s opening on September 8 (216.240 USD). The intra-week range was 3.00% (high 217.760 USD, low 211.235 USD), exhibiting a typical narrow consolidation pattern.
Weekly trading volume reached 3,928,492 shares with a turnover rate of 0.33%. Compared to the 60-day median volume, this week’s trading volume is below normal, indicating a volume contraction phase. Market participation has declined notably, with neither buyers nor sellers showing clear conviction.
In terms of weekly pattern, the stock encountered resistance at the 217 USD level and subsequently weakened, though the decline was limited and key support levels remained intact, forming a typical lower-volume pullback structure.
Valuation and Earnings
Current P/E stands at 17.23x, positioning in the lower-middle range of the past 5 years. Based on the valuation distribution data, the current P/E is at approximately the 12.4th percentile of 5-year history, meaning only about 12% of historical periods showed cheaper valuations. This indicates valuation has entered a reasonable and slightly depressed zone. Meanwhile, P/B ratio is 3.16x, relatively mid-range.
Earnings momentum remains robust. The latest Q2 2026 earnings report shows EPS of 3.46 USD, up 62.44% year-over-year; operating revenue of 21.25 billion USD, up 28.04% YoY; and net profit of 5.436 billion USD, up 60.26% YoY. This represents the fastest growth rate among the past 6 quarters.
Compared to consensus expectations, the market’s median EPS expectation for 2026 stands at 13.03 USD, with the latest forecast snapshot (starting September 3) averaging 13.078 USD. The company’s year-to-date EPS has already reached 6.89 USD (Q1 3.43 + Q2 3.46). If this pace continues, full-year results could exceed consensus expectations, suggesting potential upside to annual guidance.
Q2 net profit grew 60% year-over-year with ROE rising to 20.60%, demonstrating both high profitability quality and strong capital returns.
Capital Flows and Institutional Views
Capital flows show divergence patterns. Among this week’s net flows, retail investors saw net inflows of 536.19 (inflows minus outflows), while major institutional capital had net outflows of 395.05 (more outflows than inflows), and medium-sized capital showed net inflows of 373.03. This reflects institutional players gradually reducing positions while retail and mid-size capital gradually accumulate.
Institutional ratings remain constructive. Among 25 analyst ratings, 9 are Buy, 12 are Hold, 1 is Under, 1 is Sell, and 2 are No Opinion. Buy and Hold combined account for 84% of ratings, indicating overall institutional optimism. The latest average price target stands at 237.33 USD, representing 10.7% upside from the current price of 214.38 USD. However, it’s important to note that these ratings were last updated around September 8, carrying several days of lag.
Weekly News Themes
This week’s Morgan Stanley news focused on two main themes: First, the company increased equity stakes in external companies, including raising its stake in Pague Menos to 5% voting shares and increasing Teleperformance holdings to 5.12%. Second, Morgan Stanley actively hosted multiple major investor conferences (Morgan Stanley Laguna Conference), facilitating dialogues with defense companies including Lockheed Martin and Northrop Grumman. This reflects Morgan Stanley’s active posture in investment banking and capital operations.
Key news items:
- Morgan Stanley lifts Pague Menos stake to 5% voting shares
- Morgan Stanley lifts Teleperformance stake to 5.12% of capital
- Morgan Stanley’s Long Position In Bilibili’s Shares Decreases To 11.55% - HKEX
- Morgan StanleyEurope - ISM - MSESE - PARTIAL_RETIREMENT -11-09-2026
Divergences and Consistency
A key divergence observed in this report: low valuation + strong earnings + institutional optimism, yet capital outflows.
Possible explanations for this paradox: First, institutional ratings carry lag (based on data around September 8), while capital flow shifts happened more recently. Major investors may have anticipated headwinds (such as growth deceleration or policy changes) and reduced positions preemptively. Second, overall market risk appetite may be declining, and even financially strong stocks face valuation pressure as major players prefer to lock in gains rather than increase positions.
From a consistency perspective, low P/E and strong earnings are aligned signals. However, capital outflows disrupt this alignment, suggesting a divergence between market sentiment and fundamentals. This divergence itself warrants close monitoring—if outflows persist without earnings deterioration, a rebound opportunity may be building. Conversely, if outflows accompany downward earnings revisions, it could be an earlier warning signal.
This week’s volume contraction aligns with institutional reducing positions, reflecting market hesitancy toward near-term direction.